COLLABORATE El Meu Clínic .This link opens in a new tab.
COLLABORATE El Meu Clínic .This link opens in a new tab.
Make a donation
Navigation thread
Navigation thread
Pathogenesis of autoimmune neuronal disorders
Make a donation

Featured projects

  • IGNITION: Anti-IgLON5 disease: From Neuroinflammation to Neurodegeneration

    Principal investigator: Lidia Sabater Baudet.
    Funder: Horizon Europe.
    Code: 101227384.
    Duration: 01/11/2025 - 01/11/2029

  • Mechanisms of working memory in humans and animal models: How previous experiences affect decision-making. Identification and visualization of the involved neuronal circuits

    Principal investigator: Pablo Loza, Jaime de la Rocha Vazquez, Albert Compte Braquets, Josep Dalmau Obrador.
    Funder: Foundation Pere Mir.
    Duration: 01/01/2025 - 31/12/2026

  • La encefalitis mediada por anticuerpos LGI1: síntomas, biomarcadores y mecanismos de la fase crónica de la enfermedad

    Principal investigator: Josep Dalmau Obrador.
    Funder: Instituto de Salud Carlos III.
    Code: PI23/00858.
    Duration: 01/01/2024 - 31/12/2026

  • AMENDS: Antibody-mediated NMDA receptor encephalitis: symptoms, biomarkers, and mechanisms of the prolonged recovery phase

    Principal investigator: Josep Dalmau Obrador.
    Funder: Fundación La Caixa.
    Code: HR22-00221.
    Duration: 01/11/2022 - 30/10/2026

  • A Phase-2b, Double-Blind, Randomized Controlled Trial to Evaluate the Activity and Safety of Inebilizumab in Anti-NMDA Receptor Encephalitis and Assess Markers of Disease: The Extinguish Trial

    Principal investigator: Josep Dalmau Obrador.
    Funder: University of Utah.
    Duration: 01/04/2022 - 31/03/2027

  • Social and Psychological long-term impact of NMDA receptor encephalitis

    Principal investigator: Josep Dalmau Obrador.
    Funder: Instituto de Salud Carlos III.
    Code: AC21-2/00053.
    Duration: 01/01/2022 - 31/12/2024

  • La enfermedad por anticuerpos anti-IgLON5: modelo animal, efectos de los autoanticuerpos IgG4 in vitro y aspectos clínicos de la enfermedad

    Principal investigator: Carles Gaig Ventura, Lidia Sabater Baudet.
    Funder: Instituto de Salud Carlos III.
    Code: PI21/00165.
    Duration: 01/01/2022 - 31/12/2024

  • Factores predictores, nuevos biomarcadores y anticuerpos involucrados en las enfermedades desmielinizantes infantiles

    Principal investigator: Thais Armangue Salvador.
    Funder: Instituto de Salud Carlos III.
    Code: PI21/00316.
    Duration: 01/01/2022 - 31/12/2024

Major founders

The research of this group can be carried out thanks to the funders.

Contributors

Donations that make possible the research of this group.